4th Quarter - Report — HARM REDUCTION COALITION for HARM REDUCTION COALITION (2012)

Firm

HARM REDUCTION COALITION

Client

HARM REDUCTION COALITION

Income

$20,000

Expenses

—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Viral hepatitis testing and treatment access

Lobbyist	Covered position, as disclosed
WHITNEY ENGLANDER	Government Relations Manager

Contacted: HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); Health Resources & Services Administration (HRSA); Office of Natl Drug Control Policy (NDCP); SENATE

Alcohol and Drug Abuse ALC

Overdose prevention - prescription drug safety and access to naloxone Overturn the federal funding ban on syringe exchange services in appropriation bills

Lobbyist	Covered position, as disclosed
WHITNEY ENGLANDER	Government Relations Manager

Contacted: Office of Natl Drug Control Policy (NDCP); SENATE; Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Health Resources & Services Administration (HRSA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.